CISPLATIN INTAS cisplatin 25 mg/25 mL concentrated injection vial

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

cisplatin, Quantity: 1 mg/mL

Commercializzato da:

Accord Healthcare Pty Ltd

Forma farmaceutica:

Injection, concentrated

Composizione:

Excipient Ingredients: water for injections; hydrochloric acid; sodium chloride; sodium hydroxide

Via di somministrazione:

Intravenous

Confezione:

1

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Cisplatin Intas may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? Metastatic non-seminomatous germ cell carcinoma,? Advanced stage, refractory ovarian carcinoma,? Advanced stage, refractory bladder carcinoma,? Refractory squamous cell carcinoma of the head and neck

Dettagli prodotto:

Visual Identification: A clear, colourless to pale yellow solution in an amber glass vial; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2018-07-09